Health ❯ Healthcare ❯ Cancer Research
MGMT-unmethylated Glioblastoma Patient Data PD-L1 Prognostic Biomarkers p53 Protein Circulating Biomarkers HER2 and CD24 TROP2 Expression Circulating Tumor Cells Personalized Medicine Toxicity Management
The Brazil-led study outlines subtype-specific biomarker patterns that could guide less toxic, personalized treatments pending validation.